Komori
Medikit (7749) · InitiativeRestated

Abolition of the Executive Retirement Bonus System and Lump-Sum Payments

First written in FY2017. 5 of 7 entries say "Restated". Latest entry: FY2022.

7entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q2 – FY20222017: 320172018: 220182019: 020192020: 020202021: 120212022: 12022
Same theme, other companies
Abolition and Settlement of the Directors’ Retirement Benefit SchemeA theme 89 companies write about · 0 as a headwind · 22 as a tailwind

The whole theme swung hardest in 2025: 1 of 6 companies on the "Worse" side.

31 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 89 companies compared. The sentences above are computed from all 89.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「Regarding directors' retirement benefits, the 34th Annual General Meeting of Shareholders held on 29 June 2017 resolved to discontinue the directors' retirement benefit plan and make lump-sum payments. Accordingly, no directors' retirement benefits will be paid for periods of service after the plan was discontinued.」

    The policy of discontinuing the directors' retirement benefit plan and making no payments for periods of service after its discontinuation is being reconfirmed.
  2. FY2021RestatedAnnual report

    「Regarding directors' retirement benefits, the 34th Annual General Meeting of Shareholders held on 29 June 2017 resolved to discontinue the directors' retirement benefit plan and make lump-sum payments. Accordingly, no directors' retirement benefits will be paid for periods of service after the plan was discontinued.」

    The policy of discontinuing the directors' retirement benefit plan and making no payments for periods of service after its discontinuation is being reconfirmed.
  3. FY2018RestatedAnnual report

    「At the annual general meeting of shareholders for the fiscal year ended March 2017, the Company and its domestic consolidated subsidiaries resolved to make lump-sum payments in connection with the discontinuation of the directors' retirement benefit plan. Accordingly, the full amount of the provision for directors' retirement benefits was reversed, and the unpaid amount associated with the lump-sum payments is presented as "long-term accounts payable" under "Other" in non-current liabilities.」

    The discontinuation of the plan, the full reversal of the provision and the presentation of the long-term accounts payable associated with the lump-sum payments are also being reconfirmed in the annual report.
  4. FY2018-Q3RestatedAnnual report

    「At the annual general meeting of shareholders for the fiscal year ended March 2017, the Company and its domestic consolidated subsidiaries resolved to make lump-sum payments in connection with the discontinuation of the directors' retirement benefit plan. Accordingly, the full amount of the provision for directors' retirement benefits was reversed, and the unpaid amount associated with the lump-sum payments is presented as "long-term accounts payable" under "Other" in non-current liabilities.」

    The full reversal of the provision following the discontinuation of the directors' retirement benefit plan and the presentation of the unpaid amount as long-term accounts payable are being reconfirmed.
  5. FY2018-Q2RestatedAnnual report

    「At the annual general meeting of shareholders for the fiscal year ended March 2017, the Company and its domestic consolidated subsidiaries resolved to make lump-sum payments in connection with the discontinuation of the directors' retirement benefit plan. Accordingly, the full amount of the provision for directors' retirement benefits was reversed, and the unpaid amount associated with the lump-sum payments is presented as "long-term accounts payable" under "Other" in non-current liabilities.」

    The full reversal of the provision following the discontinuation of the directors' retirement benefit plan and the presentation of the unpaid amount as long-term accounts payable are being reconfirmed.
  6. FY2018-Q1AdvancedAnnual report

    「At the annual general meeting of shareholders for the fiscal year ended March 2017, the Company and its domestic consolidated subsidiaries resolved to make lump-sum payments in connection with the discontinuation of the directors' retirement benefit plan. Accordingly, the full amount of the provision for directors' retirement benefits was reversed, and the unpaid amount associated with the lump-sum payments is presented as "long-term accounts payable" under "Other" in non-current liabilities.」

    Following the discontinuation of the directors' retirement benefit plan, the full amount of the provision for directors' retirement benefits was reversed, and the unpaid amount associated with the lump-sum payments was reclassified to long-term accounts payable.
  7. FY2017First statedAnnual report

    「At the conclusion of the 34th Annual General Meeting of Shareholders held on 29 June 2017, the Company resolved to abolish the directors’ retirement bonus system and make lump-sum payments in lieu of the system to 9 directors, subject to a total limit of ¥1.3 billion, with payment to be made when the directors leave office.」

    The directors’ retirement bonus system was abolished at the conclusion of the Annual General Meeting of Shareholders, and changed to lump-sum payments to 9 directors subject to a total limit of ¥1.3 billion.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medikit's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.